Two T1D Patients Achieve Insulin Independence After Stem Cell Transplants
(MedPage Today) -- SAN DIEGO -- Stem cell-derived islet cell therapy continued to show promise for the management of type 1 diabetes (T1D) with severe hypoglycemia, according to results from a small phase I/II clinical trial.
All six Part A...
Source: MedPage Today Primary Care - Category: Primary Care Source Type: news
More News: Clinical Trials | Diabetes | Diabetes Type 1 | Endocrinology | Insulin | Primary Care | Stem Cell Therapy | Stem Cells | Transplants